Damora Therapeutics, Inc.
DMRA
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Mitchell Kapoor | H.C. Wainwright | 20.15 $ | 45 $ | 24.85 % | 11/06/2026 |
| David Nierengarten | Wedbush | 25.21 $ | 35 $ | 9.79 % | 28/05/2026 |